Role of exogenous and endogenous sources of estrogen on the incidence of breast fibroadenoma: Case-control study in Iran

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 5, 2011, Pages 1289-1293

  Bidgoli, Sepideh Arbabi ^a   Eftekhari, Tara ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Breast fibroadenoma; Environmental risk factors; Estrogen; Iran; PAHs

Indexed keywords

EID: 84857973810     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Arbabi Bidgoli S, Ahmadi R, Zavarhei MD (2010). Role of hormonal and environmental factors on early incidence of breast cancer in Iran. Sci Total Environ, 408, 4056-61.
2. Berkowitz GS, Canny PF, Vivolsi VA, et al (1985). Cigarette smoking and benign breast disease. J Epidemiol Community Health, 39, 308-13.
3. Bundred NJ (1994). Etiological factors in benign breast disease. Br J Surg, 81,788-9.
4. Coriaty Nelson Z, Ray RM, Gao DL, et al (2002). Risk factors for fibroadenoma in a cohort of female textile workers in Shanghai, China. Am J Epidemiol, 156, 599-605.
5. Darbre PD (2006). Environmental estrogens, cosmetics and breast cancer. Best Pract Res Clin Endocrinol Metab, 20, 121-43.
6. Dijkstra SC, Lampe JW, Ray RM, et al (2010). Biomarkers of dietary exposure are associated with lower risk of breast fibroadenomas in Chinese women. J Nutr, 140, 1302-10.
7. Dixon JM, McDonald C, Elton RA, et al (1999). Risk of breast cancer in women with palpable breast cysts: a prospective study. Lancet, 353, 1742-5.
8. Dorjgochoo T, Deming SL, Gao YT, et al (2008). History of benign breast disease and risk of breast cancer among women in China: a case-control study. Cancer Causes Control,19, 819-28.
9. Houssami N, Cheung MN, Dixon JM (2001). Fibroadenoma of the breast. Med J Aust, 19, 185-8.
10. Huang KT, Dobrovic A, Yan M, et al (2010). DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast. Breast Cancer Res Treat, 124, 555-65.
11. Irigaray P, Newby JA, Lacomme S, et al (2007). Overweight/ obesity and cancer genesis: more than a biological link. Biomed Pharmacother, 61, 665-78.
12. Jensen J, Christiansen C, Rodbro P (1985). Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med, 313, 973-5.
13. Karaduman M, Bilici A, Ozet A, et al (2007). Tissue levels of adiponectin in breast cancer patients. Med Oncol, 24, 361-6.
14. Pasqualini JR, Cortes-Prieto J, Chetrite G, et al (2007). Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma. Int J Cancer, 70, 639-43.
15. Paz-Filho G, Lim EL, Wong ML, Licinio J (2011). Associationsbetween adipokines and obesity-related cancer. Front Biosci, 1, 1634-50.
16. Rego MF, Navarrete MA, Facina G, et al (2009). Analysis of human mammary fibroadenoma by Ki-67 index in the follicular and luteal phases of menstrual cycle. Cell Prolif, 42, 241-7.
17. Rohan TE, Miller AB (1999). A cohort study of cigarette smoking and risk of fibroadenoma. J Epidemiol Biostat, 4, 297-302.
18. Rose DP, Vona-Davis L (2009). Influence of obesity on breast cancer receptor status and prognosis. Expert Rev Anticancer Ther, 9, 1091-101.
19. Sapino A, Bosco M, Cassoni P, et al (2006). Estrogen receptorbeta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol, 19, 599-606.
20. Spangler JG 1(999). Smoking and hormone-related disorders. Prim Care, 26, 499-511.
21. Wong PS, Li W, Vogel CF, et al (2009). Characterization of MCF mammary epithelial cells overexpressing the Aryl hydrocarbon receptor (AhR). BMC Cancer, 9, 234.
22. Vera-Sempere FJ, Artes Martínez J (1997). Estrogen receptors and breast fibroadenoma with suspicious traits of malignancy. Ann Med Internat, 14, 332-6.
23. Van der Heiden E, Bechoux N, Muller M, et al (2009). Food flavonoid aryl hydrocarbon receptor-mediated agonistic/ antagonistic/synergic activities in human and rat reporter gene assays. Anal Chim Acta, 637, 337-45.
24. Vessey M, Yeates D (2007). Oral contraceptives and benign breast disease: an update of findings in a large cohort study. Contraception, 76, 418-24.